Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28

Adoptive immunotherapy with tumor-specific T cells represents a promising treatment strategy for patients with malignancy. However, the efficacy of T-cell therapy has been limited by the ability to expand tumor-reactive cells with an activated phenotype that effectively target malignant cells. We ha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rosenblatt, Jacalyn, Wu, Zekui, Vasir, Baldev, Zarwan, Corrine, Stone, Richard, Mills, Heidi, Friedman, Thea, Konstantinopoulos, Panagiotis A., Spentzos, Dimitrios, Ghebremichael, Musie, Stevenson, Kristen, Neuberg, Donna, Levine, James D., Joyce, Robin, Tzachanis, Dimitrios, Boussiotis, Vassiliki, Kufe, Donald, Avigan, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2938173/
https://ncbi.nlm.nih.gov/pubmed/20145548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e3181bed253
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak